Term ends no later than Feb 25, 2032 · Medium confidence
20-year base term ends Jul 24, 2029
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Jul 24, 2009
Feb 25, 2032
Jul 9, 2013
This patent's term runs 946 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 24, 2009, when this application, 12/509,412, was filed | Jul 24, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +946 days, USPTO patent term adjustment record | Feb 25, 2032 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Feb 25, 2032 | Medium confidence |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 13, 2009 Reel 23363, frame 592 | Frey, Randy W.; Gray, Gary P. | Lensar, Inc. | Assignment of Assignor's Interest |
| Oct 1, 2013 Reel 31324, frame 917 | Lensar, Inc. | PDL Biopharma, Inc. | Security Agreement |
| Dec 15, 2015 Reel 37301, frame 363 | Lion Buyer, LLC | PDL Biopharma, Inc. | Security Interest |
| Dec 18, 2015 Reel 37328, frame 670 | Lensar, Inc. | Lion Buyer, LLC | Assignment of Assignor's Interest |
| Dec 18, 2015 Reel 37330, frame 169 | Lion Buyer, LLC | Lensar, LLC | Change of Name |
| Dec 16, 2016 Reel 40996, frame 190 | Lensar, Inc. | PDL Biopharma, Inc. | Security Interest |
| Jan 18, 2017 Reel 41258, frame 863 | Lensar, LLC | Lensar, Inc. | Assignment of Assignor's Interest |
| Feb 21, 2017 Reel 41773, frame 190 | Lensar, Inc. | PDL Biopharma, Inc. | Security Interest |
| May 11, 2017 Reel 42446, frame 763 | Lensar, Inc. | PDL Biopharma, Inc. | Security Interest |
| Jul 13, 2020 Reel 53197, frame 84 | PDL Biopharma, Inc. | Lensar, Inc. | Release of Security Interest in Intellectual Property Collateral (RF 042446/0763) |
| Aug 11, 2026 Reel 76463, frame 914 | Lensar, Inc. | Salem Five Cents Savings Bank | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Feb 25, 2032. We will not guess the cap.